ZNRF3, another E3 ubiquitin ligase, was initially reported to have inactivating mutations in adrenocortical cancer.293 In human cancers, RNF43 mutations are primarily truncating and missense, whereas ZNRF3 mutations tend to be missense mutations and deletions. This evidence concerns the gene ZNRF3 and adrenal cortex carcinoma.